Found 0 matching trials
Once-Daily Asenapine for Schizophrenia PHASE4 The investigators propose to explore: 1. the acceptance by patients of once...
Show More Location
Central Regional Hospital
Learn More & Join Trial
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) PHASE3 This study is designed to evaluate whether asenapine, which is approved by ...
Show More Location
Multiple Locations
Learn More & Join Trial
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. PHASE4 The effectiveness and efficacy of the combination of pharmacotherapy with t...
Show More Status
Active Not Recruiting
Location
Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE
Treatments Being Tested
Group A: (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol,anxiolytics: clonazepam, stedon, tavor antidepressants: seropram), Group B (Pharmacotherapy and TAU) (Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, antidepressants, Group C (Pharmacotherapy and Psychotherapy) Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, lithium, depakine Group D (Pharmacotherapy and TAU)Clozapine, quietiapine, olanzapine, aripiprazole, zyprasidone, risperidone, asenapine, paliperidone, clopixol, clonazepam, stedon, tavor, seropram, lithium, depakine) Learn More & Join Trial
An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest) N/A This post-marketing Modified Prescription-Event Monitoring (M-PEM) safety s...
Show More Location
Drug Safety Research Unit (for data collation and analysis only)
Learn More & Join Trial
An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED) PHASE2 This trial was a randomized trial to determine a patient's acceptability of...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia PHASE2 The purpose of the study is to determine whether motivation/reward deficits...
Show More Location
Kings College London
Learn More & Join Trial
Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED) PHASE3 Schizophrenia is a brain disease. The primary features of schizophrenia are...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) PHASE3 Schizophrenia is a brain disease. The primary features of schizophrenia are...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) PHASE3 Schizophrenia is a brain disease. The primary features of schizophrenia are...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) PHASE3 Treatment with conventional antipsychotics such as haloperidol has little e...
Show More Location
Multiple Locations
Learn More & Join Trial